Financials Aristo Bio-Tech and Lifescience Limited

Equities

ARISTO

INE082101010

Agricultural Chemicals

Market Closed - NSE India S.E. 07:40:28 2024-07-05 am EDT 5-day change 1st Jan Change
101.1 INR +4.23% Intraday chart for Aristo Bio-Tech and Lifescience Limited +11.90% +55.54%

Valuation

Fiscal Period: März 2023
Capitalization 1 381.6
Enterprise Value (EV) 1 568.4
P/E ratio 8.34 x
Yield 0.45%
Capitalization / Revenue 0.18 x
EV / Revenue 0.26 x
EV / EBITDA 6.46 x
EV / FCF -7,007,713 x
FCF Yield -0%
Price to Book 1.27 x
Nbr of stocks (in thousands) 6,808
Reference price 2 56.05
Announcement Date 9/4/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023
Net sales 1 2,017 2,012 1,672 1,660 2,179
EBITDA 1 68.19 45.08 43.44 54.59 87.94
EBIT 1 63.12 39.88 35.95 43.61 72.58
Operating Margin 3.13% 1.98% 2.15% 2.63% 3.33%
Earnings before Tax (EBT) 1 41.02 13.96 14.98 20.4 47.39
Net income 1 28.28 10.07 10.76 14.5 35.62
Net margin 1.4% 0.5% 0.64% 0.87% 1.64%
EPS 2 5.662 2.017 2.154 2.902 6.720
Free Cash Flow - -55 -32.38 -29.42 -81.12
FCF margin - -2.73% -1.94% -1.77% -3.72%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - 0.2500
Announcement Date 6/16/22 6/16/22 6/16/22 1/25/23 9/4/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023
Net Debt 1 140 192 221 251 187
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 2.054 x 4.256 x 5.096 x 4.592 x 2.125 x
Free Cash Flow - -55 -32.4 -29.4 -81.1
ROE (net income / shareholders' equity) - 8.54% 8.38% 10.3% 15.8%
ROA (Net income/ Total Assets) - 2.79% 2.65% 3.44% 5.13%
Assets 1 - 360.6 405.2 421.3 694.3
Book Value Per Share 2 22.60 24.60 26.80 29.70 44.30
Cash Flow per Share 2 0.8800 1.050 0.2200 0.8300 5.590
Capex 1 20.8 22 19.9 32.5 40.6
Capex / Sales 1.03% 1.09% 1.19% 1.96% 1.86%
Announcement Date 6/16/22 6/16/22 6/16/22 1/25/23 9/4/23
1INR in Million2INR
Estimates
  1. Stock Market
  2. Equities
  3. ARISTO Stock
  4. Financials Aristo Bio-Tech and Lifescience Limited